Northwest Biotherapeutics (NWBO) News Today $0.26 +0.00 (+0.89%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Headlines Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Northwest Biotherapeutics: All Is Not Well With This OneDecember 14, 2024 | seekingalpha.comCritical Analysis: Northwest Biotherapeutics (OTCMKTS:NWBO) versus Pfizer (NYSE:PFE)December 12, 2024 | americanbankingnews.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Stock Passes Below 200 Day Moving Average - Time to Sell?Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Passes Below Two Hundred Day Moving Average - Should You Sell?November 9, 2024 | marketbeat.comBehind the Bell: Arcutis BiotherapeuticsNovember 5, 2024 | nasdaq.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Shares Cross Below Two Hundred Day Moving Average - Here's WhyNorthwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Crosses Below 200-Day Moving Average - What's Next?October 26, 2024 | marketbeat.comNorthwest Registered Agent Review 2024: Features, Pricing & MoreOctober 24, 2024 | forbes.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Stock Crosses Below Two Hundred Day Moving Average - What's Next?Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Passes Below 200 Day Moving Average - Here's WhyOctober 8, 2024 | marketbeat.com0K95.IL,0P0000AFQ5,0 (0K95.IL)September 14, 2024 | nz.finance.yahoo.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Share Price Passes Below Two Hundred Day Moving Average of $0.44Northwest Biotherapeutics (OTCMKTS:NWBO) Stock Passes Below 200-Day Moving Average of $0.44September 11, 2024 | marketbeat.comNorthwest Biotherapeutics (OTCMKTS:NWBO) Stock Price Passes Below Two Hundred Day Moving Average of $0.46Northwest Biotherapeutics (OTCMKTS:NWBO) Share Price Crosses Below 200 Day Moving Average of $0.46August 28, 2024 | marketbeat.comNorthwest Biotherapeutics addresses rumors and market activityAugust 4, 2024 | uk.investing.comNorthwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews Strong Progress and Growth OpportunitiesJuly 3, 2024 | prnewswire.comNorthwest Biotherapeutics, Inc. (OTCMKTS:NWBO) Short Interest Down 14.0% in JuneNorthwest Biotherapeutics, Inc. (OTCMKTS:NWBO - Get Free Report) was the target of a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 47,353,700 shares, a decline of 14.0% from the May 31st total of 55,038,700 shares. Based on an average daily volume of 2,945,900 shares, the short-interest ratio is currently 16.1 days.June 30, 2024 | marketbeat.comNorthwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual PropertyJune 17, 2024 | prnewswire.comNorthwest Biotherapeutics Inc (NWBO) Dividend HistoryMay 25, 2024 | nasdaq.comNorthwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of DirectorsMarch 21, 2024 | prnewswire.com‘Spoofing’ case might draw back curtain on high-speed trading firmsMarch 2, 2024 | ft.comNorthwest Biotherapeutics, Inc. (NWBO)February 29, 2024 | uk.finance.yahoo.comNorthwest Biotherapeutics Stock (OTC:NWBO), Short Interest ReportFebruary 23, 2024 | benzinga.comNorthwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory CertificationFebruary 7, 2024 | finance.yahoo.comNorthwest Biotherapeutics submits marketing application to UK MHRA for DCVax-LDecember 22, 2023 | msn.comNorthwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax-L For GlioblastomaDecember 21, 2023 | finanznachrichten.deNorthwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For GlioblastomaDecember 21, 2023 | finance.yahoo.comNorthwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization ApplicationNovember 22, 2023 | finance.yahoo.comNorthwest Biotherapeutics Inc NWBOOctober 31, 2023 | morningstar.comNorthwest Bio: Another Small Filing DelayOctober 14, 2023 | msn.comNW Bio dips on announcing delay in submission of marketing application for DCVaxOctober 13, 2023 | seekingalpha.comNorthwest Biotherapeutics Shares Slide on Application DelayOctober 13, 2023 | marketwatch.comNorthwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization ApplicationOctober 13, 2023 | finance.yahoo.comNorthwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory BoardSeptember 12, 2023 | finance.yahoo.comNorthwest Bio: Is There Ever Going To Be A Right Time?August 17, 2023 | msn.comNorthwest Missouri State UniversityAugust 6, 2023 | usnews.comNorthwest HospitalAugust 4, 2023 | health.usnews.comWhy Northwest Bio Is Shunned by Savvy Health Care InvestorsJuly 15, 2023 | thestreet.comThree rounds of severe weather expected over the next 24 hours for Northwest FloridaJune 19, 2023 | pnj.comHCA Houston Healthcare NorthwestJune 13, 2023 | health.usnews.comNWBO - Northwest Biotherapeutics, Inc.May 27, 2023 | finance.yahoo.comNorthwest Bio Warns FDA May Throw Out Phase III Brain Cancer StudyMay 9, 2023 | thestreet.comNorthwest Medical Center-TucsonApril 13, 2023 | health.usnews.comNorthwest Biotherapeutics and Advent BioServices Announce Receipt of License for Commercial Manufacturing at Sawston, U.K. FacilityMarch 21, 2023 | finance.yahoo.comNorthwest Biotherapeutics Announces That It Has No Banking Relationship With SVBMarch 11, 2023 | finance.yahoo.comNorthwest Bio in $11M loan agreement with Streeterville CapitalMarch 9, 2023 | msn.comBrown-Lifespan researchers advance new vaccine to treat brain cancerJanuary 6, 2023 | bizjournals.comNorthwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews 2022 Progress and Looks Forward to Strong 2023January 6, 2023 | finance.yahoo.comUS cancer drug company accuses market makers of stock spoofingDecember 1, 2022 | ft.comCohen Milstein Files Lawsuit on Behalf of Northwest Biotherapeutics Against Major Market Makers for Market ManipulationDecember 1, 2022 | benzinga.comCancer drug company accuses US market makers of stock spoofingDecember 1, 2022 | finance.yahoo.comNorthwest Biotherapeutics: Data Is Done, Just Wait For ApprovalNovember 23, 2022 | seekingalpha.comNorthwest Biotherapeutics Reports Positive Top-Line Results From Phase 3 Trial of DCVax®-L for GlioblastomaNovember 18, 2022 | finance.yahoo.comNorthwest Biotherapeutics: Biopharma's Promising DelinquentOctober 18, 2022 | seekingalpha.com Get Northwest Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NWBO and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Coin for November 2024 (Ad)Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… NWBO Media Mentions By Week NWBO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NWBO News Sentiment▼0.550.59▲Average Medical News Sentiment NWBO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NWBO Articles This Week▼00▲NWBO Articles Average Week Get Northwest Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NWBO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NRIX News RCUS News EVTCY News KNSA News IMCR News OCUL News MESO News TVTX News NTLA News PRAX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:NWBO) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Northwest Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Northwest Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
